FB
The startup develops a biosensor instrument that enables real-time, label-free biomolecular analysis, providing high-quality affinity, kinetic, and concentration data. This technology offers healthcare companies a user-friendly, rapid, and cost-effective alternative to traditional biomolecular analysis tools.
Updated 3 months ago
Funding
$13.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a biosensor instrument that enables real-time, label-free biomolecular analysis, providing high-quality affinity, kinetic, and concentration data. This technology offers healthcare companies a user-friendly, rapid, and cost-effective alternative to traditional biomolecular analysis tools.